Literature DB >> 28365546

Joint multiple fully connected convolutional neural network with extreme learning machine for hepatocellular carcinoma nuclei grading.

Siqi Li1, Huiyan Jiang2, Wenbo Pang3.   

Abstract

Accurate cell grading of cancerous tissue pathological image is of great importance in medical diagnosis and treatment. This paper proposes a joint multiple fully connected convolutional neural network with extreme learning machine (MFC-CNN-ELM) architecture for hepatocellular carcinoma (HCC) nuclei grading. First, in preprocessing stage, each grayscale image patch with the fixed size is obtained using center-proliferation segmentation (CPS) method and the corresponding labels are marked under the guidance of three pathologists. Next, a multiple fully connected convolutional neural network (MFC-CNN) is designed to extract the multi-form feature vectors of each input image automatically, which considers multi-scale contextual information of deep layer maps sufficiently. After that, a convolutional neural network extreme learning machine (CNN-ELM) model is proposed to grade HCC nuclei. Finally, a back propagation (BP) algorithm, which contains a new up-sample method, is utilized to train MFC-CNN-ELM architecture. The experiment comparison results demonstrate that our proposed MFC-CNN-ELM has superior performance compared with related works for HCC nuclei grading. Meanwhile, external validation using ICPR 2014 HEp-2 cell dataset shows the good generalization of our MFC-CNN-ELM architecture.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Back propagation; Convolutional neural network; Extreme learning machine; Hepatocellular carcinoma nuclei grading; Multiple fully connected layers

Mesh:

Year:  2017        PMID: 28365546     DOI: 10.1016/j.compbiomed.2017.03.017

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  8 in total

Review 1.  Artificial Intelligence in Cancer Research and Precision Medicine.

Authors:  Bhavneet Bhinder; Coryandar Gilvary; Neel S Madhukar; Olivier Elemento
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

2.  Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning.

Authors:  Mingyu Chen; Bin Zhang; Win Topatana; Jiasheng Cao; Hepan Zhu; Sarun Juengpanich; Qijiang Mao; Hong Yu; Xiujun Cai
Journal:  NPJ Precis Oncol       Date:  2020-06-08

Review 3.  Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine.

Authors:  Nurbubu T Moldogazieva; Innokenty M Mokhosoev; Sergey P Zavadskiy; Alexander A Terentiev
Journal:  Biomedicines       Date:  2021-02-06

Review 4.  Artificial intelligence in gastroenterology and hepatology: Status and challenges.

Authors:  Jia-Sheng Cao; Zi-Yi Lu; Ming-Yu Chen; Bin Zhang; Sarun Juengpanich; Jia-Hao Hu; Shi-Jie Li; Win Topatana; Xue-Yin Zhou; Xu Feng; Ji-Liang Shen; Yu Liu; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2021-04-28       Impact factor: 5.742

Review 5.  Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.

Authors:  David Nam; Julius Chapiro; Valerie Paradis; Tobias Paul Seraphin; Jakob Nikolas Kather
Journal:  JHEP Rep       Date:  2022-02-02

6.  Identification of gastric cancer with convolutional neural networks: a systematic review.

Authors:  Yuxue Zhao; Bo Hu; Ying Wang; Xiaomeng Yin; Yuanyuan Jiang; Xiuli Zhu
Journal:  Multimed Tools Appl       Date:  2022-02-18       Impact factor: 2.577

7.  Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: A systematic review.

Authors:  Samy A Azer
Journal:  World J Gastrointest Oncol       Date:  2019-12-15

8.  Recurrence Risk of Liver Cancer Post-hepatectomy Using Machine Learning and Study of Correlation With Immune Infiltration.

Authors:  Xiaowen Qian; Huilin Zheng; Ke Xue; Zheng Chen; Zhenhua Hu; Lei Zhang; Jian Wan
Journal:  Front Genet       Date:  2021-12-08       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.